BR112021024474A2 - Método de diagnóstico pré-natal - Google Patents

Método de diagnóstico pré-natal

Info

Publication number
BR112021024474A2
BR112021024474A2 BR112021024474A BR112021024474A BR112021024474A2 BR 112021024474 A2 BR112021024474 A2 BR 112021024474A2 BR 112021024474 A BR112021024474 A BR 112021024474A BR 112021024474 A BR112021024474 A BR 112021024474A BR 112021024474 A2 BR112021024474 A2 BR 112021024474A2
Authority
BR
Brazil
Prior art keywords
prenatal diagnosis
diagnosis method
fetal cells
sample
fetal
Prior art date
Application number
BR112021024474A
Other languages
English (en)
Inventor
Hestbek Nicolaisen Bolette
Mathias Martin Leiding Kølvraa David
Baasch Christensen Inga
Katarina Ravn
Dahl Jeppesen Line
Lotte Hatt
Schelde Jensen Palle
Ripudaman Singh
Original Assignee
Arcedi Biotech Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arcedi Biotech Aps filed Critical Arcedi Biotech Aps
Publication of BR112021024474A2 publication Critical patent/BR112021024474A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

método de diagnóstico pré-natal. a presente invenção se refere aos métodos automatizados para isolar células fetais de uma amostra, tal como uma amostra de sangue, derivadas de uma mulher grávida. as células fetais isoladas podem ser usadas para identificar anormalidades genéticas no dna fetal.
BR112021024474A 2019-06-07 2020-06-08 Método de diagnóstico pré-natal BR112021024474A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19179087 2019-06-07
PCT/EP2020/065832 WO2020245459A1 (en) 2019-06-07 2020-06-08 Isolation of fetal cells using facs

Publications (1)

Publication Number Publication Date
BR112021024474A2 true BR112021024474A2 (pt) 2022-01-18

Family

ID=66793879

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021024474A BR112021024474A2 (pt) 2019-06-07 2020-06-08 Método de diagnóstico pré-natal

Country Status (17)

Country Link
US (2) US11573229B2 (pt)
EP (2) EP4242652A3 (pt)
JP (1) JP2022536121A (pt)
KR (1) KR20220047929A (pt)
CN (1) CN114041053A (pt)
AU (1) AU2020289708B2 (pt)
BR (1) BR112021024474A2 (pt)
CA (1) CA3142663A1 (pt)
EA (1) EA202193200A1 (pt)
ES (1) ES2955791T3 (pt)
IL (2) IL288621B2 (pt)
MX (1) MX2021015044A (pt)
PL (1) PL3980773T3 (pt)
SG (1) SG11202113242QA (pt)
UA (1) UA128273C2 (pt)
WO (1) WO2020245459A1 (pt)
ZA (1) ZA202110215B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4242652A3 (en) 2019-06-07 2023-12-06 Arcedi Biotech ApS Isolation of fetal cells using facs
CN113087793B (zh) * 2021-05-12 2022-04-12 福州迈新生物技术开发有限公司 抗ck14蛋白单克隆抗体及其细胞株、制备方法和应用
CN112980779B (zh) * 2021-05-20 2021-08-24 广州凯普医药科技有限公司 一种从孕妇宫颈脱落细胞中分离胎盘滋养层细胞的方法
EP4445135A1 (en) * 2021-12-06 2024-10-16 Arcedi Biotech ApS Isolation and diagnostics of fetal cells

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641628A (en) 1989-11-13 1997-06-24 Children's Medical Center Corporation Non-invasive method for isolation and detection of fetal DNA
US5629147A (en) 1992-07-17 1997-05-13 Aprogenex, Inc. Enriching and identifying fetal cells in maternal blood for in situ hybridization
JPH08511205A (ja) 1993-04-02 1996-11-26 ジェオ リサーチ エス．アー．エール．エル． 低温流体の噴射による切断設備と方法
WO1995003431A1 (en) 1993-07-19 1995-02-02 Aprogenex, Inc. Enriching and identifying fetal cells in maternal blood for in situ hybridization
US5714325A (en) 1993-09-24 1998-02-03 New England Medical Center Hospitals Prenatal diagnosis by isolation of fetal granulocytes from maternal blood
US5648222A (en) 1994-07-27 1997-07-15 The Trustees Of Columbia University In The City Of New York Method for preserving cells, and uses of said method
GB9603249D0 (en) 1996-02-16 1996-04-17 Univ Nottingham Foetal cell analysis
GB0009179D0 (en) 2000-04-13 2000-05-31 Imp College Innovations Ltd Non-invasive prenatal diagnosis
EP1302533A4 (en) 2000-05-16 2004-11-17 Kyowa Hakko Kogyo Kk NEW METHOD FOR INDUCING DIFFERENTIATION OF EMBRYONIC STEM CELLS IN EECTODERMAL CELLS AND THEIR USE
AU2002306768A1 (en) 2001-03-20 2002-10-03 Ortho-Clinical Diagnostics, Inc. Expression profiles and methods of use
US20030036100A1 (en) 2001-04-10 2003-02-20 Imperial College Innovations Ltd. Simultaneous determination of phenotype and genotype
FR2824144B1 (fr) 2001-04-30 2004-09-17 Metagenex S A R L Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel
EP1572087B1 (en) 2002-03-08 2008-05-14 PDL BioPharma, Inc. Antibodies against cancer antigen tmeff2 and uses thereof
US20050181429A1 (en) 2003-04-03 2005-08-18 Monaliza Medical Ltd. Non-invasive prenatal genetic diagnosis using transcervical cells
US20040197832A1 (en) 2003-04-03 2004-10-07 Mor Research Applications Ltd. Non-invasive prenatal genetic diagnosis using transcervical cells
TWI367260B (en) 2005-03-18 2012-07-01 Univ Hong Kong Chinese Method for detecting the presence of a fetus with trisomy 21 in a pregnant woman and kit thereof
WO2006119569A1 (en) 2005-05-11 2006-11-16 Genetic Technologies Limtied Methods of enriching fetal cells
DE602006017878D1 (de) 2005-12-08 2010-12-09 Fcmb Aps Nachweis fötaler zellen aus mütterlichem blut
GB0616045D0 (en) 2006-08-11 2006-09-20 Univ Bristol Blood cell separation
ES2564312T3 (es) 2007-05-01 2016-03-21 Tel Hashomer Medical Research Infrastructure And Services Ltd. Métodos y kits para detectar células fetales en la sangre materna
EP2250497B1 (en) 2008-02-18 2014-09-10 Genetic Technologies Limited Cell processing and/or enrichment methods
PT2385992E (pt) 2009-01-07 2015-04-16 Arcedi Biotech Aps Enriquecimento e identificação de células fetais em sangue materno e ligandos para esse uso
RU2011147219A (ru) 2009-04-22 2013-05-27 Клиникал Джиномикс Пти. Лтд. Способ и устройство для изолирования искомой биочастицы из биологического образца
HUE034937T2 (en) 2010-11-09 2018-03-28 Arcedi Biotech Aps Enrichment and detection of fetal cells from maternal blood and ligands for this purpose
EP4008270A1 (en) 2012-06-22 2022-06-08 Preprogen LLC Method for obtaining fetal cells and fetal cellular components
EP3489691A1 (en) 2014-05-15 2019-05-29 Kellbenx Inc. Preparation of fetal nucleated red blood cells (nrbcs) for diagnostic testing
EP4242652A3 (en) 2019-06-07 2023-12-06 Arcedi Biotech ApS Isolation of fetal cells using facs

Also Published As

Publication number Publication date
MX2021015044A (es) 2022-04-06
IL288621B2 (en) 2024-05-01
CN114041053A (zh) 2022-02-11
IL288621B1 (en) 2024-01-01
KR20220047929A (ko) 2022-04-19
CA3142663A1 (en) 2020-12-10
UA128273C2 (uk) 2024-05-22
EA202193200A1 (ru) 2022-03-17
ES2955791T3 (es) 2023-12-07
WO2020245459A1 (en) 2020-12-10
EP3980773B1 (en) 2023-07-12
AU2020289708A1 (en) 2022-01-20
US20210199664A1 (en) 2021-07-01
AU2020289708B2 (en) 2024-07-25
PL3980773T3 (pl) 2023-11-27
EP3980773A1 (en) 2022-04-13
JP2022536121A (ja) 2022-08-12
EP4242652A3 (en) 2023-12-06
IL288621A (en) 2022-02-01
US11573229B2 (en) 2023-02-07
US20230130312A1 (en) 2023-04-27
ZA202110215B (en) 2023-06-28
IL308999A (en) 2024-01-01
SG11202113242QA (en) 2021-12-30
EP4242652A2 (en) 2023-09-13
EP3980773C0 (en) 2023-07-12

Similar Documents

Publication Publication Date Title
BR112021024474A2 (pt) Método de diagnóstico pré-natal
MA39951A (fr) Détection de l'adn provenant d'un type spécifique de cellule et méthodes associées
BR112015032031A8 (pt) método para estimar uma fração de ácido nucleico em uma amostra de teste de uma mulher grávida
TW201129736A (en) Size-based genomic analysis
PH12016502112A1 (en) Method for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
MX2016016902A (es) Metodos para analizar acidos nucleicos de celulas individuales o poblaciones de celulas.
ES2571738T3 (es) Diagnóstico de aneuploidía cromosómica fetal utilizando secuenciación genómica
EP2569453A4 (en) Nucleic Acid ISOLATION METHOD
MX2017012367A (es) Producto en desarrollo de analisis de secuenciacion de alineacion y variante.
EA201892490A1 (ru) Пцр с мультиплексной оптимизированной амплификацией неправильно спаренных оснований (moma) в реальном времени для анализа состояния плода
IN2015MN00457A (pt)
IN2012DN00866A (pt)
MX347555B (es) Un metodo para analizar una muestra de sangre de un sujeto por la presencia de un marcador de enfermedad.
MX351242B (es) Un metodo para analizar una muestra de sangre de un sujeto por la presencia de un marcador de enfermedad.
NZ601079A (en) Methods and compositions for noninvasive prenatal diagnosis of fetal aneuploidies
WO2012112970A3 (en) Methods and compositions for detecting genetic material
WO2018007872A9 (en) Biomarkers for inflammatory bowel disease
AR087445A1 (es) Metodo para establecer el riesgo de enfermedad cardiovascular
SG179129A1 (en) Method for identifying whether a patient will be responder or not to immunotherapy
EP3931347A4 (en) IMPROVED METHOD FOR CLINICAL SAMPLE PREPARATION FOR NUCLEIC ACID AMPLIFICATION
Chum et al. Cataloging and profiling genes expressed in Lentinula edodes fruiting body by massive cDNA pyrosequencing and LongSAGE
ZA202101476B (en) Methods and compositions for nucleic acid isolation
MA20150026A1 (fr) Cellules souches placentaires, procédés d'isolation de ces cellules et utilisation de ces procédés
DK2604700T3 (en) METHOD OF ANALYSIS OF CELL CHROMOSOMES
Kannan et al. Transcriptomic entropy quantifies cardiomyocyte maturation at single cell level